PHILADELPHIA -- Quest Diagnostics is rolling out an antibody test consumers can order online before ever going to the doctor's office. The test is supposed to show whether someone has had or has been ...

Starting today, people in the US can order the tests on Quest's consumer testing site without visiting a doctor. At $119, the kit is one of the more expensive offered on Quest's site. It requires a ...

Quest Diagnostic DGX issued a periodical media statement on its COVID-19 testing-related business performance earlier this week. Following a robust third-quarter testing performance on rising COVID-19 ...

Quest Diagnostics Laboratories, Inc. DGX recently introduced two advanced Post-COVID-19 panels. These laboratory tests are the only wide-ranging tests available for consumers to purchase that provide ...

Quest Diagnostics DGX announced plans to launch a coronavirus (COVID-19) test service once it is prepared to receive specimens for testing from Mar 9, 2020. Through the latest service, the company ...

Narrow-moat Quest Diagnostics posted decent third-quarter results that illustrated another quarter of solid demand for non-COVID-19 tests that partially offset the significant decline in COVID-19 test ...

Quest Diagnostics has positioned itself as the leading provider of independent diagnostic testing in the U.S. by building out a network of roughly 2,300 patient service centers across the country. We ...

(Reuters) - Quest Diagnostics Inc on Wednesday launched services to support large-scale testing for the new coronavirus as companies look to bring employees back to offices safely. The company in ...

In 2022, revenues from Quest Diagnostics’ COVID-19 tests weighed in at nearly half the size of the previous year’s haul—and the testmaker is now expecting 2023’s COVID-related earnings to shrink to an ...

Quest Diagnostics DGX is challenged by declining COVID-19 testing revenues, unfavorable solvency and heightened competition. The stock carries a Zacks Rank #4 (Sell) currently. As expected, Quest ...

April 27 (Reuters) - Quest Diagnostics Inc (DGX.N), opens new tab posted first-quarter profit ahead of Wall Street estimates on Thursday as its base business helped offset a fall in COVID-19 test kits ...